Skip to main content
Download PDF

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

BMC Psychiatry volume 20, Article number: 9 (2020) Cite this article

The Original Article was published on 29 November 2019

Correction to: BMC Psychiatry (2019) 19:375

https://doi.org/10.1186/s12888-019-2359-1

After publication of our article [1] we were notified that Fig. 1 was wrongly presented.

Fig. 1
figure 1

Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline

Full size image

The correct figure and corresponding title is presented below:

The original article has been corrected.

Reference

  1. Smith-Apeldoorn SY, et al. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019;19:375. https://doi.org/10.1186/s12888-019-2359-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Groningen, University Medical Center Groningen, PO box 30.0001, 9700, RB, Groningen, The Netherlands

    Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Jeanine Kamphuis & Robert A. Schoevers

  2. Department of Psychiatry, PsyQ Haaglanden, Parnassia Psychiatric Institute, The Hague, The Netherlands

    Jolien K. E. Veraart

  3. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    Antoinette D. I. van Asselt

  4. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    Daan J. Touw

  5. Department of Psychology, University of Groningen, Groningen, The Netherlands

    Marije aan het Rot

Authors
  1. Sanne Y. Smith-Apeldoorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jolien K. E. Veraart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeanine Kamphuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antoinette D. I. van Asselt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daan J. Touw
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marije aan het Rot
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert A. Schoevers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanne Y. Smith-Apeldoorn.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith-Apeldoorn, S.Y., Veraart, J.K.E., Kamphuis, J. et al. Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry 20, 9 (2020). https://doi.org/10.1186/s12888-019-2398-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12888-019-2398-7

BMC Psychiatry

ISSN: 1471-244X

Contact us